📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics. (2020)

First Author: Arshad U
Attributed to:  MICA: New combination therapy against MDR TB targeting the respiratory chain funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cpt.1909

PubMed Identifier: 32438446

Publication URI: http://europepmc.org/abstract/MED/32438446

Type: Journal Article/Review

Volume: 108

Parent Publication: Clinical pharmacology and therapeutics

Issue: 4

ISSN: 0009-9236